Hubbry Logo
SnusSnusMain
Open search
Snus
Community hub
Snus
logo
8 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Snus
Snus
Snus
View on Wikipedia
from Wikipedia

White (right) and original snus (left). The white version is dryer, with no added water, to last longer. The original version's added water creates a swifter effect.
Tobacco-based snus of the Swedish brand General, marketed by Swedish Match.

Snus (/snuːs/ SNOOSS; Swedish: [ˈsnʉːs] ⓘ) is a Swedish tobacco product. It is consumed by placing a pouch of powdered tobacco leaves under the lip for nicotine to be absorbed through the oral mucosa.[1] Snus, not to be confused with nicotine pouches, consists of ground up tobacco leaves, salt, an alkalizer (e.g. sodium carbonate, sodium bicarbonate) and (optionally) flavorings. The final product is sold as both loose tobacco, and in portions with the tobacco mixture contained in a small teabag-like pouch.

The manufacturing process of snus differs from that of other oral tobacco products. Snus tobacco is heated and pasteurized rather than cured or fermented, resulting in a less harmful product which contains a lower concentration of TSNA carcinogens in comparison to other traditional tobacco products.[2] Though research on the connection between snus and disease such as cancer is not conclusive, and some studies find no associations between snus consumption and an increased risk of cancer,[3] some do suggest a link to risk of oral and pharyngeal cancer.[4]

The warning text "causes cancer" was removed from snus packaging in Sweden and other countries because scientific evidence indicates that the cancer risk associated with snus is significantly lower than that of smoking. The shift in labeling aims to provide accurate information while still cautioning consumers about potential health concerns.

Nicotine products in general have been linked to reproductive harms such as stillbirth, premature birth, and low birth weight.[5] Conversely, non-tobacco-based nicotine pouches (also known as "nic pouches") are classified as non-carcinogenic[6][7][8] since nicotine itself is not a carcinogen. However, they are still harmful to cardiovascular health due to their nicotine content, and are associated with moderately higher risk of cardiovascular disease, stroke, and reproductive harms.[9][10] The main causes for mortality from smoking including cardiovascular disease from the effects of smoke on vascular coagulation and blood vessel walls are not caused primarily by nicotine and hence not to be considered equal to the moderate cardiovascular health risks from nicotine pouches.[11]

Legal status of tobacco-based snus. The sale of tobacco-based snus is banned in the EU (except in Sweden).[12]

The sale of tobacco-based snus is illegal in several countries, including Australia, New Zealand and all European Union (EU) countries except for Sweden.[13] Non-tobacco nicotine pouches are presently not regulated at EU-level. It is the most common type of tobacco product in Sweden[14] and Norway[15] and is also available in Switzerland. Some European countries, such as the United Kingdom,[16] Ireland[17] and Estonia,[18] allow the sale of non-tobacco-based snus. Snus is also available in the United States.

Overview

[edit]
Lös Snus is a loose tobacco without the portion pouches.

Snus is made from air-dried/pasteurized tobaccos from various parts of the world. In earlier times, tobacco for making snus was laid out for drying in Scania and Mälardalen, Sweden. Later, Kentucky tobaccos were used. The ground tobacco is mixed with water, salt, an alkalizing agent such as sodium carbonate or sodium bicarbonate (E500), and aroma, and is prepared through heating under pressure. After the heating process, food grade aromas are typically added. In Sweden, snus is regulated as a food product and, for this reason, all ingredients are listed on the label of each individual package (can) of snus. Moist snus contains more than 50% water, and the average use of snus in Sweden is approximately 800 grams (16 units) per person each year. About 12% (1.1 million people) of the population in Sweden use snus.[19] Unlike dipping tobacco and chew, most snus does not undergo the fermentation process, but is instead steam-pasteurized. Pasteurization inhibits the growth of bacteria that facilitate the formation of tobacco-specific nitrosamines, while preserving the desired texture and mouthfeel of the snus. The absorption of nicotine, the desired primary alkaloid in tobacco, greatly depends on the nicotine content in the snus and the pH of the final product.[20] A voluntary quality standard for snus products has been introduced (Gothiatek) that sets maximum levels for certain controversial constituents including nitrosamines, heavy metals, and polyaromatic hydrocarbons. Most manufacturers of Scandinavian type snus adhere to this standard.

Snus is sold in containers of various sizes, originally made of porcelain, wood, silver, or gold. Portioned snus usually comes in plastic tins of 20 to 24 portions, containing about 0.75 to 1 gram of snus each, while loose snus is mostly sold in wax coated cardboard containers with plastic lids (similar to dip snuff), at 42 g (50 g before 2008). Mini-portion and medium-portion snus are increasingly popular formats. Most of these products come in tins containing 20 portions, of either 0.65 or 0.5 grams each for a total of just under 13 or 10 grams, particularly with those for whom concealing their use of smokeless tobacco in places is of utmost importance.

Snus is available in two main types:

  • Loose snus (Swedish: lössnus) is a moist powder that can be shaped into a cylindrical or spherical form using the fingertips or a specialized cylindrical device. This final product is commonly known as a pris ('pinch'), buga, prilla, or prell (slang). Some individuals, particularly long-time users, opt to simply pinch the tobacco and place it under their upper lip (known as a farmer's pinch or living snus). However, the popularity of loose snus has gradually been overtaken by portioned alternatives.
  • Portion snus (Swedish: portionssnus) is a convenient and discreet form of snus that comes in small teabag-like sachets filled with moist powder. It is available in smaller quantities compared to loose powder snus. There are two varieties of portion snus:
    • Original portion: This traditional form was introduced in 1973. The sachet material is moisturized during manufacturing, resulting in a brown, moist pouch.
    • White portion: This form has a milder taste and slightly slower release. The sachet material is not moisturized during manufacturing, resulting in a white, dry pouch. The tobacco within the portion material has the same moisture content as original portion snus, but the nicotine and flavor are delivered somewhat slower due to the drier sachet. Notably, "white portion" refers to the style, not the color. Some white portion snus use a black material instead of white, yet are still considered "white portion". Examples of such snus include General Onyx, Grovsnus Svart (Black), and Blue Ocean (Blue).
    • The Stingfree portion is a patented pouch for snus and modern oral nicotine pouches, approved in the US and Europe. It features a protective side that effectively reduces the burning sensation and irritation on the user's gum and oral mucosa.[21]

Portioned snus comes in three sizes: mini, normal/large, and maxi. The weights vary, but most packages disclose the net weight. Mini portions weigh around 0.5 g, normal portions weigh 0.8 to 1 g, and maxi portions weigh up to 1.7 g. Some brands offer regular and long versions of the normal size sachet.

The nicotine content varies among brands, with the most common strength being 8 mg per gram of tobacco. Stark and extra stark varieties have higher nicotine content, with stark varieties containing 11–14 mg and extra stark varieties containing up to 22 mg. Siberia brand has an "Extremely Strong" snus with 43 mg of nicotine per gram of tobacco, the highest available.[22]

Usage

[edit]

Snus is typically used by being placed under the upper lip. This is true for both loose snus and portion snus. The pris (pressed pellet of loose snus) or pouch is typically left in place for anywhere between 30 and 120 minutes. No spitting is required, but some (especially new users) may prefer to.[23]

Snus is not cured, so it can spoil much faster than cured tobacco. While tobacco-based snus is typically refrigerated for short term storage (up to a few months), it is typically frozen for longer term storage of a year or more. It can stay unrefrigerated for a week or more without spoilage. Some tobacco-based snus products are shipped very dry, so they have extended shelf life without needing any refrigeration. This makes them slower to initially "drip", as there is no appreciable moisture in the packet.

Differences with other oral tobacco products

[edit]

See also: Smokeless tobacco

Some forms of tobacco consumed in the mouth may be categorized as:

Swedish snus
A moist form of smokeless tobacco which is usually placed under the upper lip, and which does not result in the need for spitting. It is sold either as a moist powder known as loose snus, or packaged into pouches known as portion snus. Snus is often mildly flavored with food-grade smoke aroma, bergamot, citrus, juniper berry, herbs and/or floral flavors. Most Scandinavian snus is produced in Sweden and regulated as food under the Swedish Food Act.[24]
American snus
Available since the late 1990s, this is similar to the Scandinavian form, but usually has a lower moisture content and lower pH, resulting in lower bioavailability of nicotine than Scandinavian varieties, meaning less is available for absorption.[25] American snus is often flavored, e.g., with spearmint, wintergreen, vanilla or fruit (e.g. cherry), and may contain sugar.[26]
Nasal snuff
Mostly English, German, and Scandinavian, this is referred to as luktsnus in Swedish and luktesnus in Norwegian, and as "Scotch snuff"[citation needed] in the US, is a dry, powdered form of snuff. It is insufflated – "sniffed" but not deeply "snorted" – through the nose. It is often mentholated or otherwise scented.
Chewing tobacco
North American and European product, also known as chew (or in some Southern US dialects as chaw or dip). It is tobacco in the form of short or long, loose leaf and stem strands (like pipe tobacco or longer), or less commonly of chopped leaves and stems compressed into blocks called plugs, or even finely ground pieces compressed into pellets. A few brands are cut into much finer loose strands, like cigarette rolling tobacco. Chew is placed between the cheek and the gums, or actively chewed. It causes copious salivation, especially when chewed, and due to its irritant (even nauseating) effect on the esophagus, this "juice" usually requires spitting. Chewing tobacco is a long-established North American form of tobacco (derived from traditional use of raw tobacco leaf by Indigenous peoples of the Americas), and is also legal in the European Union. Chewing tobacco is sometimes flavored, e.g. with wintergreen, apple, or cherry.
Dipping tobacco
Also known as dip, spit tobacco or, ambiguously, as moist snuff, this is a common American form of tobacco. It is moist, and somewhat finely ground, but less so than snus. Dipping tobacco (so called because users dip their fingers into the package to pinch a portion to insert into the mouth) is placed between the lower lip or cheek and the gums; it is not used nasally. As with chewing tobacco, salivation is copious, and usually spat out. Dipping tobacco is usually flavored, traditionally with wintergreen or mint, though many other flavorings are now available, while some unflavored brands remain popular. Beginning in the mid-1980s, several brands have packaged American dipping tobacco in porous pouches like those used for many brands of Scandinavian and American snus.
Chema
This Algerian product is a moist tobacco similar to Scandinavian snus in many respects. Outside of Algeria, it is most widely known as "Makla", a name that originates from the Algerian brand "Makla El Hilal", which first produced this type of smokeless tobacco during the French colonization.[27] It is placed in the upper lip in a manner similar to snus; it differs in that it is more finely ground and has an even higher nicotine content and pH level. Sales within the European Union are legal due to its classification as a chewing tobacco. Its safety in comparison to snus has not been studied sufficiently.
Naswar
A central Asian product which is a moist, powdered form of tobacco, often green and sometimes caked with the mineral lime and/or wood ash. It is used like dipping tobacco or put under the tongue, and is pungent and often heavily flavored, e.g. with culinary oils (cardamom, sesame), the fruit lime, menthol, etc. Naswar contains nicotine, which can lead to addiction, and its use has been associated with increased risks of oral cancers, gum disease, and cardiovascular issues due to the presence of tobacco-specific nitrosamines and other harmful chemicals.[28]

Snus, dry snuff, and dipping tobacco are distinct products that some English speaking people may refer to as snuff but are all processed and used in very different ways, each with their own sets of risks.

Health risks

[edit]
Further information: Health effects of snus
Warning label on a container of Swedish snus. The text reads: "This tobacco product may damage your health and is addictive". Note the "best before" date and list of ingredients, which is required by Swedish law.

Various national and international health organizations stated that using snus is addictive, represents a health risk, has no safe level use, and is not a safe substitute for smoking.[29][30][31][32] Using snus can cause a number of adverse health effects such as esophageal cancer, pancreatic cancer, stomach cancer, colorectal cancer,[33] cardiovascular disease and stroke.[34][35] Snus can also cause adverse reproductive effects including stillbirth, premature birth, low birth weight. Nicotine in snus products that are used during pregnancy can affect how a baby's brain develops in the womb.[5] Quitting snus use is as challenging as smoking cessation.[36] There is no scientific evidence that using snus can help a person quit smoking, although widespread snus-usage is correlated with lower rates of smoking.[31][37][38]

Tobacco shop in Neuchâtel, Switzerland in 2020: Advertising for tobacco (here for snus Epok from British American Tobacco) is authorized inside the shop.

History

[edit]
Catch lid found on many snus tins, which snaps in and out of place. The small compartment is typically used for the temporary storage of used snus portions.

Snus has a long history of use, reaching back to the 16th century and concentrated in Sweden. Its origin lies in an invention by Jean Nicot (1530–1600), a French diplomat residing in Portugal who cultivated tobacco in his garden, and was one of the pioneers in recognizing the medicinal properties of tobacco. Nicot is also the originator of the word nicotine.[39] Nicot meticulously dried and ground the tobacco leaves into a fine powder, which could be inhaled as snuff. He presented this powder to Catherine de’ Medici (1519–1589), the Queen of France, in an effort to alleviate her migraines. The use of snuff quickly gained popularity among the French court and the upper-class citizens, becoming a fashionable trend. By the early 17th century, the practice of using nasal snuff had also spread to Sweden.[40]

Tobacco use became so prevalent in Sweden that in 1724, King Fredrik I issued a decree mandating that Swedes cultivate their own tobacco. Consequently, farmers and homesteaders started grinding their own locally grown tobacco.

Due to manual laborers typically working outside where frequent use of a dry, finely ground nasal snuff is not convenient, they opted to crush their tobaccos into a paste-like consistency and allowed it to ferment in jars for several weeks. The final product was then portioned and placed under the lip for extended periods of time, eventually gaining popularity as snus.

Ettan is the oldest still extant snus brand, which dates to 1822. Its founder, Jakob Fredrik Ljunglöf, introduced pasteurization into snus making, reducing production time by several weeks and preventing microbial contamination.[41][42] In the years that followed, numerous manufacturers further improved of snus manufacturing, leading to the flourishing of many brands. Several of these brands from that era continue to exist.[citation needed]

In 1914, the Swedish parliament nationalised the entire tobacco industry. This led to the transformation of numerous tobacco companies into the state-owned monopoly known as AB Svenska Tobakmonopolet. As a result, the number of available tobacco products decreased significantly from approximately four hundred local brands to just seventeen, although these were now distributed nationwide. Consequently, employment within the industry experienced a fifty percent decline. In the 1960s, Sweden decided to abolish the import and sales monopoly on tobacco.[43] AB Svenska Tobaksmonopolet later merged with the match manufacturer Swedish Match and was listed on the stock market in 1996.

See also

[edit]
Wikimedia Commons has media related to Snus.

References

[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

Snus

View on Grokipedia
from Grokipedia

Snus is a heat-treated moist snuff tobacco product originating from Sweden in the early 19th century, composed primarily of ground air-cured tobacco leaves, water, salt, and sometimes sodium carbonate, formed into loose or portioned pouches placed under the upper lip for nicotine absorption without combustion or spitting. Developed from earlier forms of oral snuff dating back to the 16th century, snus gained prominence in Sweden during the 20th century, with consumption peaking in the early 1900s before stabilizing; today, daily use among Swedish men stands at approximately 22%, while female use is around 4%, contributing to a parallel decline in cigarette smoking prevalence from higher levels in prior decades to about 6% recently. Empirical analyses indicate that snus substitution for smoking has averted thousands of premature deaths annually in Sweden by reducing exposure to smoke-related carcinogens. Multiple studies demonstrate that snus poses substantially lower risks for key health outcomes—such as lung cancer, cardiovascular disease, and overall mortality—compared to cigarette smoking, though it is not risk-free and carries associations with oral and pancreatic cancers at elevated but diminished levels relative to combustible tobacco. Legally, snus remains uniquely permitted for sale in Sweden within the European Union due to a protocol exemption upon accession, while banned elsewhere in the EU since 1992 despite evidence of its harm-reduction potential, reflecting regulatory divergences prioritizing precautionary bans over comparative risk assessments.

Definition and Composition

Core Characteristics

Snus is a pasteurized, moist smokeless tobacco product originating from Sweden, consisting of ground air-cured tobacco leaves mixed with water, salt, and sodium carbonate to achieve a pH of approximately 8 to 8.5. It is designed for oral use by placing a portion under the upper lip, where nicotine is absorbed through the mucous membranes without combustion, spitting, or inhalation. Unlike fermented smokeless tobaccos such as American moist snuff, snus undergoes steam pasteurization during production, which reduces levels of tobacco-specific nitrosamines (TSNAs). Traditional Swedish snus maintains a moisture content of about 45-55%, contributing to its soft texture and facilitating nicotine release. Total nicotine concentrations typically range from 7 to 20 mg per gram of product (wet weight), with un-ionized (freebase) nicotine levels elevated due to the alkaline pH, enhancing buccal absorption efficiency compared to lower-pH products. The product is available in loose form for manual portioning or pre-portioned sachets, often flavored with bergamot, herbs, or fruits to mask tobacco taste while preserving discreet, odor-minimal use. Snus differs from other oral tobaccos like chewing tobacco or nasal snuff in its non-fermented processing, portioned delivery to minimize mess, and emphasis on controlled nicotine delivery without expectoration. This formulation results in lower moisture variability and TSNA content relative to non-pasteurized smokeless products, as documented in comparative chemical analyses.

Ingredients and Formulation

Snus is primarily composed of finely ground tobacco leaves that are air-cured or sun-cured to develop flavor and reduce nitrosamine precursors, blended with water to achieve a moisture content typically ranging from 20% to 60%. Salt, in the form of sodium chloride at concentrations of approximately 1.5% to 3.5%, is added to enhance flavor and act as a preservative, while sodium carbonate serves as an alkalizer to raise the pH to an alkaline level (usually 8.0 to 8.5), facilitating nicotine release and absorption through the oral mucosa. Additional minor ingredients include humectants such as glycerin or to maintain moisture and prevent drying, along with flavorings derived from natural sources like herbs, fruits, or spices to impart varieties such as mint, bergamot, or notes. Unlike fermented smokeless tobaccos, snus formulation avoids ; instead, the tobacco mixture undergoes through steaming or heating to eliminate harmful bacteria like while preserving the product's moist texture and low levels of (TSNAs) when produced under standards like GothiaTek. This process results in a product where constitutes the bulk (often over 40% by dry weight), with levels varying from 4 to 20 mg per gram depending on the brand and strength designation. Variations in formulation exist between Swedish-style snus and American adaptations, with the latter sometimes exhibiting higher TSNA concentrations (e.g., NNN + levels up to 2.5 times greater) due to differences in tobacco curing or , though both share core components of , salt, and pH adjusters. Swedish snus adheres to stricter quality controls, limiting additives and ensuring , which contributes to its distinct chemical profile compared to dry snuffs or .

Production and Variants

Manufacturing Process

The manufacturing process of snus, a moist oral tobacco product originating in Sweden, emphasizes pasteurization over fermentation to minimize bacterial growth and tobacco-specific nitrosamines (TSNAs). This heat treatment, typically conducted at 70-80°C, distinguishes snus from other smokeless tobaccos like American dip, which often rely on fermentation that can elevate TSNA levels. Swedish producers adhere to standards such as GOTHIATEK®, which imposes strict limits on contaminants like heavy metals and TSNAs throughout the chain, using non-genetically modified, air- or sun-dried tobacco varieties selected for low initial levels of undesired substances. The process commences with tobacco grinding, where dried leaves are broken down into coarse, intermediate, and fine particles, often to a powder finer than 0.5 mm for uniformity. The ground tobacco is then transferred to closed blenders and mixed with water, salt (sodium chloride for taste and preservation), and sodium carbonate to adjust pH levels, achieving a moist consistency. This blend undergoes pasteurization in computer-controlled vessels, where it is heated to eliminate nitrite-forming microbes and pathogens, followed by rapid cooling to preserve moisture and prevent overcooking. Post-pasteurization, humectants such as propylene glycol (typically 3-5%) or glycerol are incorporated to maintain moisture and texture, alongside natural or artificial flavorings for aroma development. The mixture is then aged in cold storage—often at around 4°C for several days to 1-2 weeks—allowing flavors to mature without further microbial activity. For loose snus, the final product is filled into paraffin-coated cardboard cans, sealed, weighed, and labeled; portioned variants involve metering the blend into heat-sealable cellulose fiber pouches (approximately 0.7 g each), sealing and cutting them, then packing into polypropylene cans. Throughout, automated quality controls monitor nicotine content, moisture (around 30-50%), and pH (typically 8.0-8.5) to ensure consistency and compliance with food safety regulations like Sweden's Food Act.

Types of Snus

Snus is primarily classified into two formats: loose snus and portioned snus. Loose snus consists of finely ground, moist tobacco that users manually portion into a small wad or ball for placement under the upper lip. This traditional form allows customization of size and shape to individual preference, with moisture content typically around 30-50% to facilitate nicotine release without combustion. Portioned snus, introduced in the 1970s, comes pre-packaged in small, teabag-like cellulose or synthetic pouches containing ground tobacco, eliminating the need for manual handling. Original portions, the earliest variant launched in 1973, feature moist tobacco that promotes saliva production and a steady nicotine drip, often resulting in a fuller flavor release but potential teeth staining from the darker tobacco. White portions, developed later for reduced drip, use drier tobacco with added salt and flavorings, yielding a whiter appearance, less moisture leakage, and slower nicotine absorption to minimize oral irritation. White dry portions further reduce moisture levels, enhancing discretion and comfort during use. Portion sizes vary within these categories, including large or original (about 1 gram per pouch for robust users), slim (narrower for subtle fit), and mini (smaller, 0.5 grams or less for beginners or extended wear). While flavors such as mint, bergamot, or tobacco dominate across types, and nicotine strengths range from mild (4-8 mg/g) to extra strong (20+ mg/g), these attributes modify rather than redefine the core formats. American snus variants, often drier and pasteurized differently, diverge from Swedish standards but retain similar loose or portioned structures.

Usage Practices

Consumption Method

Snus is consumed orally by placing the product—a pre-formed pouch or a user-measured pinch—between the and the adjacent gum, enabling trans-mucosal absorption of without ingestion, chewing, or expectoration. This placement leverages the oral mucosa's vascularity for delivery, with effects onset typically within 1-2 minutes and peaking around 5 minutes. For portioned snus, which constitutes the majority of modern variants, the user extracts a single pouch from its container and positions it under the upper lip, often offset to one side for optimal fit and minimal interference with speech or swallowing. The pouch remains in place for 5 to 60 minutes, adjusted based on desired nicotine yield and flavor intensity, after which it is discarded without reuse. Users are advised against swallowing the pouch or its contents to prevent gastrointestinal discomfort. Loose snus usage involves dispensing a small quantity—typically 1-2 grams—directly from the can, which the user may lightly compact or shape into a wad before inserting it under the upper lip in a manner analogous to portioned forms. This format permits customization of portion size, potentially yielding a more rapid or intense nicotine release compared to fixed pouches. Placement duration mirrors that of portions, though loose material may conform more readily to the oral contours. The upper lip is the standard site for both formats due to lower salivary flow relative to the lower lip, which minimizes drip, extends flavor and nicotine persistence up to an hour, and reduces irritation risk. Lower lip placement, while feasible, accelerates release and increases saliva production, often leading to quicker disposal. No preparation such as moistening is required, as snus arrives in a humidified state optimized for immediate use.

User Demographics and Cultural Context

Snus use is concentrated in Sweden and Norway, where it exhibits the highest prevalence rates in Europe, with daily usage among adults reaching approximately 16% in Sweden and 15% in Norway as of 2022. In Sweden, usage remains predominantly male-dominated, with 20.7% of men and 3.5% of women reporting smokeless tobacco use in surveys from the early 2010s, though recent data indicate a narrowing gender gap, particularly among younger cohorts where female daily nicotine pouch use (often overlapping with snus variants) has risen to 15% among those aged 16-29 compared to 11% for men. Age patterns show peak prevalence among working-age adults, with snus use 1.7 times higher among 40-year-olds than 60-year-olds among men, and even more pronounced among women at younger ages. Outside Scandinavia, prevalence drops sharply due to regulatory bans; for instance, snus use in other European countries averages below 1%, while in the United States, it remains niche, primarily among tobacco enthusiasts or Swedish expatriates, with no widespread demographic penetration reported in national surveys. In Norway, daily snus use among men stood at 18.2% in 2010, declining slightly in gender disparity by 2018 as female uptake increased to over 10%, reflecting broader trends in smokeless tobacco substitution for cigarettes. Overall, snus users skew toward former or current smokers, with 45% of daily users in European cohorts having quit smoking, underscoring its role as a harm-reduction alternative rather than a primary initiation product among never-smokers, who comprise less than 25% of users across usage categories. Socioeconomic factors influence uptake, with higher rates among manual laborers and urban dwellers historically, though contemporary data highlight its cross-class appeal in Nordic societies. Culturally, snus embodies a centuries-old Scandinavian tradition originating in 16th-century Sweden, where tobacco was moistened with salt and water for sublingual placement, evolving from elite courtly snuff to a staple among industrial workers during the 19th-century urbanization. This shift aligned with practical needs for discreet, smoke-free nicotine delivery during work breaks, embedding snus in everyday routines and social bonds, often shared among friends as a marker of camaraderie and national identity. In Sweden, it has contributed to the lowest EU smoking rates, with 19% of men and 4% of women using it daily as of 2013, positioning snus as a culturally accepted public health divergence from combustible tobacco. Norway mirrors this, with snus supplanting cigarettes post-World War II, driven by consumer preference for flavored, portioned variants that fit modern lifestyles. Beyond Nordics, snus lacks deep cultural roots, often viewed through regulatory lenses rather than tradition, limiting its social integration elsewhere.

Health Effects

Risks Relative to Smoking

Snus use entails substantially lower health risks than cigarette smoking primarily due to the absence of combustion, which eliminates exposure to tar, carbon monoxide, and numerous volatile carcinogens produced by burning tobacco. Epidemiological data from Sweden, where snus has displaced smoking among many men, demonstrate that tobacco-attributable mortality rates are the lowest in the European Union, with snus users exhibiting reduced incidence of smoking-related diseases such as lung cancer and chronic obstructive pulmonary disease compared to smokers. Relative risks for respiratory conditions are negligible with snus, as it involves no inhalation of smoke; cohort studies confirm no significant association with lung cancer, contrasting sharply with the elevated risks from smoking. For cancers of the oral cavity, pharynx, and esophagus, exclusive snus use shows no demonstrable increase in risk in large Swedish cohorts, unlike the strong causal link with smoking; a systematic review of exclusive snus users found relative risks near unity for these sites when compared to non-users, far below those for smokers. Pancreatic cancer risk may be modestly elevated with heavy snus use (≥7 cans/week), but remains lower than for smokers based on dose-response analyses. Cardiovascular disease risks, including fatal myocardial infarction and stroke, are elevated for both snus users and smokers relative to non-tobacco users, yet comparative analyses indicate snus confers a statistically lower hazard; for instance, adjusted relative risks for cardiovascular mortality are approximately 1.2–1.4 for snus versus 2.0 or higher for smoking in pooled Swedish cohorts. Overall mortality follows a similar pattern: snus use is linked to increased all-cause mortality (hazard ratio ~1.3–1.5 versus non-users), but this is markedly attenuated compared to smoking (hazard ratio ~2.0–3.0), supporting snus as a harm reduction tool in populations switching from cigarettes. These findings persist after controlling for confounders like age and prior smoking history, though some studies note potential confounding from dual use or cessation dynamics.

Specific Adverse Outcomes

Health risks from snus use are dose-dependent, with limited specific data on occasional use available, but general evidence indicates lower risks for occasional versus regular or daily use regarding nicotine addiction, oral health issues (e.g., lesions), potential increased risk of pancreatic and esophageal cancer, and cardiovascular effects; however, no level of tobacco use is considered completely safe. Snus use is associated with the development of oral mucosal lesions, such as snuff-induced lesions or white patches (snuslesions), which occur due to direct contact with the mucosa and are characterized by keratinization and . These lesions are typically reversible upon cessation but can persist in long-term users, with histological changes including epithelial and in some cases, though progression to is rare for Swedish snus. Studies indicate no significant elevation in risk among exclusive Swedish snus users compared to non-users, as evidenced by meta-analyses showing relative risks near unity after adjusting for confounders like . Regarding , early cohort studies among Swedish construction workers suggested a potential twofold increased risk, but larger pooled analyses of multiple cohorts, including over 400,000 participants followed for up to 33 years, found no association ( 0.96, 95% CI 0.83-1.11) after adjustment for and other factors. Similarly, systematic reviews confirm no consistent link for Swedish snus, distinguishing it from higher-risk smokeless products like Indian gutkha. Cardiovascular effects include acute elevations in heart rate and blood pressure during use, particularly in older users, due to nicotine's sympathomimetic actions. Long-term studies show mixed results: while overall cardiovascular disease mortality may not be elevated, snus use in never-smokers is linked to increased stroke risk, especially ischemic stroke (hazard ratio approximately 1.3-1.6 in cohort data). Pooled analyses also report higher all-cause and cardiovascular mortality among snus users (e.g., hazard ratio 1.28 for all-cause in men), though risks remain substantially lower than for smoking. Snus delivers nicotine, fostering dependence comparable to cigarette smoking, with cross-sectional surveys showing similar levels of nicotine dependence scores (e.g., half of daily users reporting low to high dependence). Withdrawal symptoms upon cessation include irritability and cravings, and long-term follow-up indicates many users maintain habitual use post-smoking cessation attempts. Other potential outcomes include possible increased risk of esophageal cancer, though evidence is limited and probabilistic rather than definitive.

Empirical Evidence from Long-Term Studies

A of 278,897 Swedish construction workers followed from 1971 to 2009 found no significant association between snus use and increased risk of , with s of 0.79 (95% CI: 0.52–1.21) for ever-users and 1.02 (95% CI: 0.62–1.70) for current users compared to never-users of . The same study reported a of 0.45 (95% CI: 0.24–0.85) for among current snus users, suggesting a protective or neutral effect potentially due to substitution from . For , the relative risk was 0.82 (95% CI: 0.52–1.30) for current users, indicating no elevated risk relative to non-users. A 2023 systematic review of 22 studies on exclusive Swedish snus users, including cohort and case-control designs spanning decades, concluded no consistent of increased for oral, esophageal, gastric, pancreatic, or lung cancers, with most relative risks near or below 1.0 after adjusting for confounders like . However, the review noted limited data on long-term exclusive use and potential underpowering for rare outcomes. Swedish population data from 1987–2013 showed snus users had oral cancer incidence rates comparable to never-tobacco users, contrasting with elevated rates among smokers. In cardiovascular outcomes, a cohort of 43,396 Swedish men followed from 1991–2014 linked current snus use to a hazard ratio of 1.28 (95% CI: 1.15–1.43) for fatal myocardial infarction, particularly among heavy users (>4 cans/week, HR 1.60), though no association with non-fatal MI or overall CVD incidence after multivariable adjustment. The study observed no increased risk for major heart diseases, valvular issues, or abdominal aortic aneurysm. A separate analysis of 169,236 men from 2002–2018 found snus associated with higher all-cause mortality (HR 1.26, 95% CI: 1.15–1.39) and cardiovascular death (HR 1.28, 95% CI: 1.09–1.51) among never-smokers, potentially mediated by nicotine's effects on hemodynamics. Long-term Swedish registries indicate snus substitution has contributed to national lung cancer rates 50–70% lower than EU averages, with modeling estimating 25–30% of the decline attributable to snus displacing cigarettes since the 1970s. A counterfactual analysis projected that absent snus, smoking-attributable mortality in Sweden would have been 10–20% higher through 2020, based on cohort data linking snus to higher smoking cessation rates (quit ratios 1.5–2.0 times higher for snus users). Some evidence suggests elevated post-diagnosis cancer mortality among snus users (HR 1.2–1.4 for all cancers combined), though confounded by dual use or detection bias in Nordic cohorts. Overall, these studies underscore snus risks as substantially lower than smoking for cancer but highlight dose-dependent cardiovascular concerns.

Regulation and Market Dynamics

In the European Union, the sale of tobacco-based snus has been prohibited since the adoption of the 1992 Tobacco Products Directive, which aimed to restrict novel oral tobacco products due to concerns over health risks and gateway effects to smoking, though empirical evidence on these risks remains debated relative to combustible tobacco. Sweden secured a permanent exemption upon its 1995 accession to the EU, allowing domestic manufacture and sale under national regulations, including age restrictions to 18 years and health warnings on packaging. Non-EU Norway permits snus sales, taxing it at NOK 1.28 per gram and enforcing an 18-year purchase age, contributing to high prevalence as a smoking alternative. Post-Brexit, the United Kingdom retained the EU ban, prohibiting commercial sale and marketing of snus under the Tobacco and Related Products Regulations 2016, though personal possession and import for individual use remain permissible without quantity limits specified for travelers. In North America, snus is legal in the United States, classified as a tobacco product under FDA jurisdiction since 2009, requiring premarket authorization for marketing claims; as of November 2024, eight General snus variants hold modified risk tobacco product status, allowing claims of reduced harm compared to cigarettes for adult smokers, with sales restricted to those 21 and older. In Canada, snus falls under the Tobacco and Vaping Products Act, permitting personal import but prohibiting commercial sales without Health Canada authorization, which has not been granted as of 2025, effectively limiting availability to cross-border purchases. Australia and New Zealand maintain outright bans on snus importation, sale, and use, enacted under strict tobacco control laws prioritizing elimination of non-combustible options despite their lower carcinogen profiles relative to smoking. Globally, snus is authorized for sale in 77 to 79 countries, primarily outside the EU, including the United States, Norway, and various nations in Africa, Asia, and South America, while banned in 39 jurisdictions dominated by EU members.

Recent Developments and Trade Challenges

The global snus market expanded to an estimated USD 3.01 billion in 2023, with projections indicating growth to USD 4.10 billion by 2030 at a compound annual growth rate of 4.7%, fueled by demand for reduced-risk nicotine products amid declining cigarette use. In Nordic countries, snus adoption has accelerated the shift away from smoking; Norwegian data from Statistics Norway reveal that increasing snus prevalence over the past decades has paralleled a sharp drop in smoking rates, from over 30% in the 1990s to under 10% by 2023. Regulatory hurdles continue to impede snus trade, most notably the European Union's longstanding ban on its sale outside Sweden, enacted in 1992 under the Tobacco Products Directive and upheld despite evidence of snus's harm reduction potential relative to combustible tobacco. This restriction confines Swedish exports primarily to permitted markets like the United States and Switzerland, while fostering cross-border smuggling within the EU, as nicotine products evade harmonized controls. In 2025, Sweden escalated challenges to analogous restrictions on tobacco-free nicotine pouches—often termed "white snus"—by formally objecting to proposed bans in France and Spain, contending that such national measures infringe the EU single market's free movement of goods and risk stifling innovation in lower-risk alternatives. The Swedish government highlighted that France's comprehensive prohibition on white snus products would unduly limit intra-EU trade, echoing critiques of the original snus ban's disproportionate impact on evidence-based harm reduction strategies. Meanwhile, EU-wide regulatory fragmentation persists, with member states imposing varied taxes and classifications on pouches, complicating manufacturers' compliance and market access. In the United States, the Food and Drug Administration has authorized certain snus products via premarket tobacco product applications, enabling market penetration and contributing to overall sector expansion, though youth uptake of related nicotine pouches has prompted heightened scrutiny. These developments underscore ongoing tensions between public health objectives and trade liberalization, with Sweden advocating for science-driven policies over blanket prohibitions.

Historical Development

Origins in Scandinavia

Snus, a moist smokeless tobacco product placed under the upper lip, traces its roots to Sweden, where the term "snus" first appeared in a 1637 customs document recording imports from Porvoo, Finland. Tobacco itself arrived in Sweden around 1638 via shipments from the short-lived Swedish colony on the Delaware River in North America, initially used in pipe smoking and nasal snuff forms common across Europe. By the mid-17th century, domestic cultivation began in regions like Skåne, Gränna, and Alingsås, supported by figures such as Jonas Alströmer, who promoted agricultural innovations including tobacco alongside potatoes. In the early , Swedish users adapted dry nasal snuff into a moist, ground variant, creating the precursor to modern snus by mixing leaves with and salt for sublingual placement, which offered convenience for workers and farmers avoiding the mess of snuff. This evolution addressed practical needs in a society where farming expanded to approximately 70 towns by the late 1700s, reflecting widespread adoption amid growing domestic production. The form stabilized further in the early 1800s, incorporating alongside salt and to enhance flavor and retention, distinguishing it from drier snuffs and establishing its core composition. Though concentrated in Sweden, early snus practices influenced neighboring Scandinavian countries like Norway, where similar oral tobacco use emerged through cultural exchange, but Sweden remained the epicenter due to its extensive tobacco infrastructure and innovations in moist preparation. By the 19th century, snus had become a staple among Swedish laborers, underscoring its origins as a pragmatic alternative to smoking in an era of limited fire safety and ventilation in rural and industrial settings.

Modern Commercialization and Global Spread

The modern commercialization of snus in Sweden gained momentum in the mid-20th century through innovations aimed at improving usability and hygiene. In 1973, the first pre-portioned snus product, named "Smokeless," was launched to assist smokers in quitting by offering a discreet alternative. This development was followed in 1977 by the introduction of white-portion snus with the Tre Ankare brand, which reduced staining and dripping, enhancing consumer appeal. Swedish Match, originating from tobacco operations established in 1915 under Sweden's state monopoly, consolidated its position as the dominant producer after merging match and tobacco divisions in 1992 and adopting the Swedish Match name in 1994. The company further advanced product standards by implementing the GothiaTek quality framework in the late 1990s, which minimized contaminants like nitrosamines through controlled pasteurization and ingredient selection. Global expansion faced significant regulatory obstacles, notably the European Union's Directive 92/41, enacted in 1992, which prohibited the sale of oral tobacco products including snus across member states to curb perceived risks from novel smokeless variants like U.S.-style products. Sweden secured a unique exemption for domestic sales upon its EU accession in 1995, preserving its market while banning exports to other EU countries. Undeterred, Swedish Match targeted non-EU markets, entering a joint venture with Philip Morris International in February 2009 to develop and market snus products internationally, with a primary focus on the United States. This partnership facilitated the 2016 U.S. launch of ZYN, a tobacco-derived nicotine pouch variant, which achieved substantial sales growth amid rising demand for reduced-risk alternatives. Further milestones included the U.S. Food and Drug Administration's October 2019 authorization for Swedish Match to market eight snus products with modified risk claims, stating they pose a lower risk of cancer compared to cigarettes for adult smokers switching completely. Snus consumption remains robust in non-banned regions like Norway, where per capita use rivals Sweden's, and has expanded in markets such as Switzerland and select Asian countries through legal sales channels. The global snus market, valued at USD 3.01 billion in 2023, reflects ongoing commercialization driven by portioned formats and harm reduction perceptions, projecting growth to USD 4.10 billion by 2030 at a 4.7% CAGR, largely fueled by North American and Scandinavian demand. Despite proliferation, access in banned jurisdictions often relies on informal imports or tourism, underscoring persistent trade barriers.

References

  1. https://pmc.ncbi.nlm.nih.gov/articles/PMC3119032/
  2. https://pmc.ncbi.nlm.nih.gov/articles/PMC6961908/
  3. https://www.swedishmatch.com/Our-business/smokefree/History-of-snuff/
  4. https://academic.oup.com/ije/article/49/6/2041/6042990
  5. https://snusforumet.se/en/new-report-reveals-snus-use-patterns-in-sweden/
  6. https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-024-01095-7
  7. https://pubmed.ncbi.nlm.nih.gov/16195209/
  8. https://www.fda.gov/media/131923/download
  9. https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-020-00380-5
  10. https://gsthr.org/resources/snus/legal-status-snus/
  11. https://www.snusdaddy.eu/inspiration/where-is-snus-legal
  12. https://www.accessdata.fda.gov/Static/widgets/tobacco/MRTP/18%2520appendix-6a-environ-snus-monograph-2013.pdf
  13. https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-019-0335-1
  14. https://gsthr.org/resources/briefing-papers/what-is-snus/what-is-snus/
  15. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0227837
  16. https://www.pmi.com/our-science/snus-snuff-nicotine-pouches-explained
  17. https://pmc.ncbi.nlm.nih.gov/articles/PMC5896472/
  18. https://www.swedishmatch.com/Our-business/smokefree/Snus-production/
  19. https://www.accessdata.fda.gov/Static/widgets/tobacco/MRTP/13%2520appendix-2l-sm-ws-03/sm%2520ws%252003%2520final%2520study%2520protocol.pdf
  20. https://bmcchem.biomedcentral.com/articles/10.1186/s13065-019-0548-0
  21. https://loyal-machine.com/blog/snus-manufacturing-process/
  22. https://www.snusdirect.com/blog/how-is-snus-made
  23. https://www.snusdirect.com/blog/the-different-snus-pouches
  24. https://www.northerner.com/us/the-northerner/research/what-is-snus
  25. https://www.mysnus.com/snus-format-and-sizes
  26. https://snuskingdom.com/snus-type.html
  27. https://www.northerner.com/us/the-northerner/how-to/how-to-use-snus
  28. https://www.mysnus.com/how-to-use-snus
  29. https://www.northerner.com/uk/the-northerner/guide/how-long-does-snus-last
  30. https://snusdaddy.com/inspiration/how-long-do-nicotine-pouches-last
  31. https://www.snusdirect.com/articles/how-to-snus
  32. https://www.haypp.com/uk/nicopedia/guide/a-beginners-guide-on-how-to-use-snus-and-nicotine-pouches
  33. https://www.snus24.com/snus-blog/item/3-main-differences-between-loose-snus-and-portion-snus/
  34. https://snuscore.com/blogs/news/why-place-nicotine-pouches-under-the-upper-lip
  35. https://snusline.com/blog/why-does-it-make-a-difference-where-i-place-my-snus/
  36. https://nicopods.ie/where-do-you-place-a-nicotine-pouch/
  37. https://journals.sagepub.com/doi/10.1177/29767342241255816
  38. https://academic.oup.com/eurpub/article/26/5/817/2197571
  39. https://www.statista.com/topics/13475/snus-market-in-sweden/
  40. https://pmc.ncbi.nlm.nih.gov/articles/PMC3267833/
  41. https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-020-09604-6
  42. https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-020-00419-7
  43. https://snusforumet.se/en/snus-culture-history-from-royal-courts-to-working-hands/
  44. https://www.weforum.org/stories/2017/06/how-swedens-switch-to-snus-could-be-a-lesson-for-the-rest-of-us/
  45. https://gsthr.org/resources/briefing-papers/how-snus-is-replacing-smoking-in-norway-a-revolution-led-by-consumers-and-product-innovation/how-snus-is-replacing-smoking-in-norway-a-revolution-led-by-consumers-and-product-innovation/
  46. https://www.thebulletin.be/swedish-experience-how-snus-tradition-helped-country-achieve-smoke-free-status
  47. https://pmc.ncbi.nlm.nih.gov/articles/PMC4154048/
  48. https://www.sciencedirect.com/science/article/abs/pii/S0140673607606771
  49. https://www.nature.com/articles/sj.bdj.2019.55
  50. https://onlinelibrary.wiley.com/doi/10.1002/ijc.34643
  51. https://www.sciencedirect.com/science/article/pii/S2214750024001628
  52. https://www.tandfonline.com/doi/full/10.1080/08958370500224698
  53. https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-021-01979-6
  54. https://pmc.ncbi.nlm.nih.gov/articles/PMC7825961/
  55. https://www.nature.com/articles/s41598-022-16467-x
  56. https://www.fhi.no/en/publ/2019/health-risks-from-snus-use2/
  57. https://www.sciencedirect.com/science/article/pii/S0278691518309384
  58. https://journals.sagepub.com/doi/10.1177/1403494820919572
  59. https://pubmed.ncbi.nlm.nih.gov/28486772/
  60. https://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.30773
  61. https://www.swedishmatch.com/Snus-and-health/Research-on-snus/Cardiovascular-disease/
  62. https://pmc.ncbi.nlm.nih.gov/articles/PMC8103653/
  63. https://www.nature.com/articles/s41598-023-42233-8
  64. https://pmc.ncbi.nlm.nih.gov/articles/PMC6121467/
  65. https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-020-00405-z
  66. http://umu.diva-portal.org/smash/record.jsf?pid=diva2:1708504
  67. https://pmc.ncbi.nlm.nih.gov/articles/PMC1747791/
  68. https://www.tobaccotactics.org/article/snus-eu-ban-on-snus-sales/
  69. https://www.euractiv.com/news/sweden-moves-to-stop-nicotine-pouches-meeting-the-fate-of-snus/
  70. https://www.eureporter.co/health/2025/10/11/how-the-swedish-model-can-power-a-smoke-free-eu/
  71. https://nordicwelfare.org/pub/Use_of_nicotine_products_among_youth_in_the_Nordic_and_Baltic_countries_-_An_overview/regulations-across-the-nordic-and-baltic-countries.html
  72. https://www.northerner.com/uk/the-northerner/guide/is-snus-legal-in-the-uk
  73. https://www.haypp.com/uk/nicopedia/facts/snus-and-nicotine-pouches-in-the-uk
  74. https://www.fda.gov/tobacco-products/fda-renews-authorization-8-general-snus-products-be-marketed-reduced-risk-claim
  75. https://www.snusline.com/blog/the-regulation-of-snus-in-the-usa/
  76. https://nativesmokes4less.one/is-snus-legal-in-canada/
  77. https://www.ordernicotinepouches.com/en-us/pages/nicotine-pouches-legal-by-country
  78. https://gsthr.org/faq-smoking-and-nicotine/us-smokeless-and-snus/which-countries-allow-the-sale-of-snus/
  79. https://gsthr.org/resources/snus/
  80. https://www.grandviewresearch.com/industry-analysis/snus-market
  81. https://pmc.ncbi.nlm.nih.gov/articles/PMC8900178/
  82. https://www.government.se/press-releases/2025/05/government-issues-detailed-opinion-on-frances-proposal-to-ban-white-snus/
  83. https://smokefreesweden.org/2025/04/29/sweden-praised-for-its-stand-against-european-restrictions-on-safer-alternatives-to-smoking/
  84. https://www.tobaccoasia.com/features/nicotine-pouches-at-a-crossroads/
  85. https://keck.usc.edu/news/use-of-nicotine-pouches-increases-significantly-among-u-s-teens/
  86. https://snusforumet.se/en/swedens-success-in-nicotine-pouch-regulations-lessons-for-the-eu/
  87. https://nordstjernan.com/news/emigration/7399
  88. https://snusforumet.se/en/the-history-of-snus/
  89. https://www.linkedin.com/pulse/short-history-swedish-snus-tor-kj%25C3%25B8lberg
  90. https://www.snusochtandsticksmuseum.se/en/explore/snus/snus-history/
  91. https://www.northerner.com/us/swedish-match
  92. https://www.swedishmatch.com/Our-company/Company-history/
  93. https://rollcall.com/2025/04/10/in-sweden-a-focus-on-smokeless-tobacco/
  94. https://www.tobaccotactics.org/article/swedish-match/
  95. https://uu.diva-portal.org/smash/get/diva2:1780984/FULLTEXT01.pdf
  96. https://www.tobaccotactics.org/article/cigarette-companies-investing-in-snus/
  97. https://gsthr.org/resources/snus/global-status-snus/
  98. https://www.snusdirect.com/articles/eu-snus-ban
Add your contribution
Related Hubs
User Avatar
No comments yet.